Clinical Trials Logo

Fracture of Foot clinical trials

View clinical trials related to Fracture of Foot.

Filter by:
  • None
  • Page 1

NCT ID: NCT05844280 Not yet recruiting - Fracture of Foot Clinical Trials

The Role of Blood Flow Restriction Therapy in Postop Rehabilitation of Foot and Ankle Injuries

Start date: August 2026
Phase: N/A
Study type: Interventional

The purpose of the study is to determine the role of blood flow restriction (BFR) + neuromuscular electrical stimulation (NMES) in improving post-operative physical therapy and recovery after ankle fracture surgery. We expect to see improved muscle strength, less muscle wasting, and improved functional recovery after surgery when making these additions to routine post-operative (postop) physical therapy protocols.

NCT ID: NCT05555459 Recruiting - Hallux Valgus Clinical Trials

Performance and Safety Evaluation of Inion CompressOn Screw in Foot and Ankle Surgeries. PMCF Investigation

Start date: September 28, 2022
Phase: N/A
Study type: Interventional

The study in question is a post market clinical follow up (PMCF) study to evaluate the safety and performance of bioabsorbable headless compression screw Inion CompressOn in selected fracture, osteotomy and arthrodeses operations of the foot and ankle. The study recruits 125 adult patients who meet the acceptance criteria. The follow-up time for each study patient is 4 years. The study is a single center single group study which is conducted in Tampere University Hospital (TAYS) in Finland. The main focus of the study in terms of performance is to evaluate the bone healing/ossification of operated areas. The main focus of the study in terms of safety is to evaluate the occurrence of adverse events and required revision surgeries that are or might be related to the study device.

NCT ID: NCT02161016 Terminated - Fracture of Foot Clinical Trials

A Clinical Study of Outcomes in Foot and Ankle Bone Grafting Using map3® Cellular Allogeneic Bone Graft

Start date: June 2014
Phase: Phase 4
Study type: Interventional

This is a single arm pilot study in patients requiring surgical fusion in the foot or ankle. Patients will receive map3® Cellular Allogeneic Bone Graft containing donor matched stem cells. This cohort study will enroll 24 patients total at 1 site. After subjects have signed an informed consent, the baseline visit and examinations will be completed. Patients will be evaluated at 2 weeks, 6 weeks, 3 months, 6 months, 12 months, and 24 months after surgery.